Diosmin
-
Post Date:
Oct 11,2018
-
Expiry Date:
Oct 11,2019
-
Detailed Description:
Cas No. :520-27-4
Specs:BP/USP/EP
Payment Method: T/T advance,LC sight,LC 90days
1. Treatment of venous lymphatic insufficiency associated symptoms (heavy legs, pain, discomfort, soreness early morning) - the treatment of acute hemorrhoid attack on a variety of symptoms.
2. With vitamin P-like effects, can reduce vascular fragility and abnormal permeability, but also for the control of the adjuvant treatment of hypertension and arteriosclerosis, for the treatment of capillary fragility was better than rutin, hesperidin and stronger, and has low toxicity characteristics.
3. Of the vein system to play its active role in: - reduce venous distensibility and venous stasis zone.
4. In the micro-circulatory system, so that the normalization of capillary wall permeability and increase their resistance.
-
CAS Registry Number:
520-27-4
-
Synonyms:
;3',5,7-trihydroxy-4'-methoxyflavone 7-rutinoside;3,5,7-Trihydroxy-4-methoxyflavone-7- rutinoside;5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-4H-chromen-7-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside;5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-4H-chromen-7-yl 6-O-(6-deoxyhexopyranosyl)hexopyranoside;5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-4H-chromen-7-yl 6-O-(6-deoxy-alpha-D-mannopyranosyl)-beta-D-glucopyranoside;
-
Molecular Formula:
C28H32O15
-
Molecular Weight:
608.5447
-
Molecular Structure:
-
Hazard Symbols:
Xi:Irritant;
-
Risk Codes:
R36/37/38:;
-
Safety Description:
S26:;
S36:;
Inquiry